Anti-HSV gD/Envelope glycoprotein D Antibody (E317) from ProteoGenix; catalogue ARO-A23077; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Anti-HSV gD/Envelope glycoprotein D Antibody (E317) is a highly specific and sensitive antibody designed for the detection and quantification of the glycoprotein D (gD) of Herpes Simplex Virus (HSV). This antibody is an essential tool for researchers studying the biology and pathogenesis of HSV, as well as developing antiviral therapies.
HSV is a highly contagious virus that causes a range of diseases, including oral and genital herpes. The virus enters the host cells through interactions between its envelope glycoproteins and host cell receptors. Among these glycoproteins, gD plays a crucial role in viral entry by binding to specific receptors on the host cell surface. Anti-HSV gD/Envelope glycoprotein D Antibody (E317) specifically recognizes and binds to the gD protein, making it an ideal tool for studying the role of gD in HSV infection.
Anti-HSV gD/Envelope glycoprotein D Antibody (E317) is widely used in various applications, including Western blotting, immunofluorescence, and ELISA. Its high specificity and sensitivity make it an excellent choice for detecting and quantifying gD in biological samples. This antibody can also be used for immunoprecipitation and immunohistochemistry, providing valuable insights into the localization and expression of gD in infected cells and tissues.
Anti-HSV gD/Envelope glycoprotein D Antibody (E317) has been successfully used in numerous research studies. For example, it has been used to study the role of gD in viral entry and membrane fusion, as well as the development of HSV vaccines. This antibody has also been used to investigate the molecular mechanisms of HSV latency and reactivation. Additionally, it has been used to evaluate the effectiveness of antiviral drugs against HSV.
In summary, Anti-HSV gD/Envelope glycoprotein D Antibody (E317) is a highly specific and sensitive tool for studying the biology and pathogenesis of HSV. Its main applications include Western blotting, immunofluorescence, and ELISA, and it has been successfully used in various experimental settings. With its ability to specifically target gD, this antibody is a valuable asset for researchers in the field of virology and herpes research. Order now and advance your research with the power of Anti-HSV gD/Envelope glycoprotein D Antibody (E317).
ProteoGenix catalogue number ARO-A23077. For research use only.
Target: Envelope glycoprotein D, gD; Clonality: Monoclonal Antibody; Applications: Neutralization, ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | Neutralization |
|---|---|---|---|---|---|---|---|---|---|
| Envelope glycoprotein D, gD |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
